Cytokinetics, Inc. (CYTK)
68.55
-2.93
(-4.10%)
USD |
NASDAQ |
Jun 08, 15:39
Cytokinetics Market Cap : 8.517B for June 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Ionis Pharmaceuticals, Inc. | 12.18B |
| Alnylam Pharmaceuticals, Inc. | 38.92B |
| BioMarin Pharmaceutical, Inc. | 10.89B |
| Regeneron Pharmaceuticals, Inc. | 64.40B |
| BridgeBio Pharma, Inc. | 13.21B |
Market Cap Related Metrics
| PS Ratio | 78.57 |
| PEG Ratio | -0.3467 |
| Price | 68.55 |
| Earnings Yield | -9.98% |
| PEGY Ratio | -0.3467 |